Latest Media Releases (Page 3) | Finance News Network

Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

CARETEQ - Response to ASX Query (ASX:CTQ)

Dear Lisa, Careteq Limited (CTQ) – Response to ASX Query Letter We refer to ASX’s letter dated 26 June 2023. The Company provides the following responses to the queries in the l...read more

Arovella Therapeutics - Share Purchase Plan (SPP) Closing Date Extended (ASX:ALA)

Highlights: SPP Closing Date extended by one week to 5.00pm (AEST) Thursday, 6 July 2023 MELBOURNE, AUSTRALIA 29 June 2023: Arovella Therapeutics Ltd (ASX: ALA), a biotechnology company focus...read more

National Seniors Australia Signs Exclusive with Careteq (ASX:CTQ)

National Seniors Australia to exclusively promote and market Careteq’s Assistive Living Technology solutions through its large network targeting the over 50s The non-profit is Au...read more

Arovella Therapeutics - Share Purchase Plan (SPP) Offer Booklet (ASX:ALA)

To view the notification, download the attached PDF.

Arovella completes $4M placement & launches $1M SPP (ASX:ALA)

Highlights: -- Firm commitments received for A$4.1 million Placement to new and existing institutional and sophisticated investors at A$0.045 per share. -- Share Purchase Plan for existing eligi...read more

Arovella Therapeutics - Trading Halt (ASX:ALA)

To view the announcement, download the attached PDF.

Arovella's OroMist R&D facility closure completed (ASX:ALA)

Highlights: Perth-based R&D facility closure has been completed Closure reduces expenditure by approximately $1.5m per annum Part of Arovella’s continued focus on its...read more

CARETEQ - Q3-FY23 ACTIVITIES REPORT & APPENDIX 4C (ASX:CTQ)

Number of new Sofihub contracts won jumps 55% over previous quarter to 34 with a further 18 paid trials currently running Eight of the 34 contracts won and 11 of the 18 tr...read more

Arovella Therapeutics - Response to ASX Query (ASX:ALA)

For more information, download the attached PDF.

Arovella Therapeutics - Quarterly Appendix 4C and Activities Report (ASX:ALA)

MELBOURNE, AUSTRALIA 24 April 2023: Arovella Therapeutics Ltd (ASX: ALA), a biotechnology company focused on developing its invariant Natural Killer T (iNKT) cell therapy platform for cancer treatme...read more

CARETEQ - ShareCafe Webinar Presentation (ASX:CTQ)

To view the presentation, please download the attached PDF.

Arovella Therapeutics - Response to ASX Aware Query (ASX:ALA)

Dear Sean Response to Aware Query Arovella Therapeutics Limited (ASX:ALA) (“Arovella” or “the Company”) refers to your Aware Query dated 17 April 2023 (“Aware Que...read more

Arovella Therapeutics - ALA-101 confers survival benefit in leukemia model (ASX:ALA)

-- Arovella has presented new data at the American Association for Cancer Research (AACR) Annual Meeting for CAR19-iNKT cells produced using a new 3rd-generation lentiviral vector as planned for cli...read more

Arovella Therapeutics - Response to ASX Price Query (ASX:ALA)

Response to Price Query Arovella Therapeutics Limited (ASX:ALA) (“Arovella” or “the Company”) refers to your Price Query dated 14 April 2023 and provides the followin...read more

Careteq forms Strategic JV (ASX:CTQ)

Highlights: Careteq to merge its Ward MM business with Mederev in a JV to be called Embedded Health Solutions and create one of Australia’s largest aged care medication manageme...read more

Viewing: 31 - 45 of 200 Previous | Next